1Life Healthcare $282 million IPO
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $281.75 million initial public offering by 1Life Healthcare, Inc…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Denali Therapeutics $207 million stock offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $207 million public offering of common stock of Denali Therapeutics,…
Kodiak Sciences Inc. $317 Million Follow-On Offering
Davis Polk advised the joint bookrunning managers and representatives of the several underwriters in connection with a $317.4 million public offering of common stock by Kodiak Sciences Inc…
Agios Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 9,487,500 shares of common stock of…
Davis Polk Advises Hudson Group on Its Acquisition of a Controlling Stake in the Assets of OHM Concession Group
Davis Polk is advising Hudson Group in connection with its acquisition of a controlling stake in the assets of OHM Concession Group LLC. The addition of OHM adds notable food and beverage…
Davis Polk Advises Hudson Group on Its Acquisition of Brookstone Airport Stores from Apex Digital
Davis Polk is advising Hudson Group in connection with its acquisition of assets related to the operation of Brookstone stores in U.S. airports from Apex Digital, Inc. Hudson has also…
Aprea Therapeutics, Inc. Initial Public Offering
Davis Polk advised the underwriters in connection with the $97.75 million initial public offering of 6,516,667 shares of common stock of Aprea Therapeutics, Inc., which includes 850,000…
Tokyo Century acquisition of Aviation Capital Group from Pacific Life
Davis Polk is advising Tokyo Century Corporation in connection with its acquisition of the remaining 75.5% interest it does not own in Aviation Capital Group LLC from Pacific Life Insurance…
Deciphera Pharmaceuticals Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the SEC-registered offering by Deciphera Pharmaceuticals, Inc. of 10,810,810 shares of common stock for gross proceeds…
Stemline Therapeutics, Inc. Common Stock Offering
Davis Polk advised the underwriters in connection with the SEC-registered offering of 5,750,000 shares of common stock of Stemline Therapeutics, Inc. for total gross proceeds of…